Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,890
Closed -$658K 25
2022
Q2
$658K Hold
11,890
0.62% 21
2022
Q1
$766K Hold
11,890
0.61% 21
2021
Q4
$694K Sell
11,890
-91,500
-88% -$5.13M 0.55% 22
2021
Q3
$5.39M Sell
103,390
-23,565
-19% -$1.29M 1.28% 16
2021
Q2
$6.81M Hold
126,955
1.33% 14
2021
Q1
$6.5M Buy
126,955
+22,700
+22% +$1.09M 1.43% 14
2020
Q4
$4.64M Buy
104,255
+92,365
+777% +$3.78M 1.17% 19
2020
Q3
$432K Hold
11,890
0.14% 30
2020
Q2
$428K Hold
11,890
0.16% 29
2020
Q1
$407K Hold
11,890
0.19% 28
2019
Q4
$629K Hold
11,890
0.24% 36
2019
Q3
$622K Hold
11,890
0.27% 34
2019
Q2
$652K Hold
11,890
0.34% 34
2019
Q1
$595K Hold
11,890
0.34% 34
2018
Q4
$542K Buy
+11,890
New +$529K 0.38% 32

Other funds holding AFL

Act Two Investors's AFL Position: Q3 2022 in Review

Act Two Investors sold out of Aflac (AFL) in Q3 2022, closing a stake of 11,890 shares — an estimated $658K sold.

Act Two Investors first reported a position in AFL in Q4 2018 and held it in 15 quarters. The position peaked at $6.81M in Q2 2021. 1,182 funds tracked by Wall St. Rank hold AFL as of Q3 2022.

  • Act Two Investors reported no remaining Aflac position as of Q3 2022 after selling out during the quarter.
  • Act Two Investors sold 11,890 Aflac shares in Q3 2022, an estimated $658K.
  • Act Two Investors first reported a position in Aflac in Q4 2018 and held it in 15 quarters.
  • Act Two Investors's Aflac position peaked at $6.81M in Q2 2021.
  • 1,182 funds tracked by Wall St. Rank held Aflac as of Q3 2022.

Based on Act Two Investors's 13F filing for Q3 2022, filed 10 Nov 2022.